Cannabinoid – Derived pharmaceuticals industry review summit

Join us as we attend Cannabinoid – Derived pharmaceuticals industry review summit digital event.

The first Cannabinoid Derived Pharmaceuticals Industry Review Summit, taking place virtually, uniting experts from across large pharma, innovative biotechs, academia and solution providers to overcome all the end to end challenges which are holding back therapeutic and commercial success in cannabinoid-based drug development.

To find out more and register to the event click here.

Speak to our attending delegate:

• Helen Domeshek, Ph.D., Business Development, Drug Substance